Pseudotemporal whole blood transcriptional profiling of COVID-19 patients stratified by clinical severity reveals differences in immune responses and possible role of monoamine oxidase B
Broderick, C.; Rivero Calle, I.; Gomez Carballa, A.; Gomez-Rial, J.; Li, H. K.; Mehta, R.; Jackson, H.; Salas, A.; Martinon-Torres, F.; Sriskandan, S.; Levin, M.; Kaforou, M.; BioAID Consortium, ; GEN-COVID Study Group,
Show abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with highly variable clinical outcomes. Studying the temporal dynamics of host whole blood gene expression during SARS-CoV-2 infection can elucidate the biological processes that underlie these diverse clinical phenotypes. We employed a novel pseudotemporal approach using MaSigPro to model and compare the trajectories of whole blood transcriptomic responses in patients with mild, moderate and severe COVID-19 disease. We identified 5,267 genes significantly differentially expressed (SDE) over pseudotime and between severity groups and clustered these genes together based on pseudotemporal trends. Pathway analysis of these gene clusters revealed upregulation of multiple immune, coagulation, platelet and senescence pathways with increasing disease severity and downregulation of T cell, transcriptional and cellular metabolic pathways. The gene clusters exhibited differing pseudotemporal trends. Monoamine oxidase B was the top SDE gene, upregulated in severe>moderate>mild COVID-19 disease. This work provides new insights into the diversity of the host response to SARS-CoV-2 and disease severity and highlights the utility of pseudotemporal approaches in studying evolving immune responses to infectious diseases.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Blood transcriptomes of anti-SARS-CoV2 antibody positive healthy individuals with prior asymptomatic versus clinical infection 96%
- Plasma gradient of soluble urokinase-type plasminogen activator receptor is linked to pathogenic plasma proteome and immune transcriptome and stratifies outcomes in severe COVID-19 96%
- Exposing Limitations of Clinical Laboratory Tests in COVID-19 and the Promise of Immunological Biomarkers 95%
Similar papers in this journal
- Specific Dynamic Variations in the Peripheral Blood Lymphocyte Subsets in COVID-19 and Severe Influenza A Patients: A Retrospective Observational Study 93%
- Serum neopterin levels in relation to mild and severe COVID-19 92%
- Ruxolitinib versus Dexamethasone in Hospitalized Adults with Covid-19: multicenter matched-controlled study 92%
Similar papers in this journal
- Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren’s disease 93%
- Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure 93%
- Towards standardization of immune functional assays 92%
Similar papers in this journal
- COVID-19 susceptibility variants associate with blood clots, thrombophlebitis and circulatory diseases 95%
- SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets 94%
- Novel prognostic determinants of COVID-19-related mortality: a pilot study on severely-ill patients in Russia 94%
Similar papers in this journal
- LEF1-AS1 deregulation in the peripheral blood of patients with persistent post-COVID symptoms 95%
- Multi-omics profiling reveals phenotypic and functional heterogeneity of neutrophils in COVID-19 94%
- Kawasaki Disease patient stratification and pathway analysis based on host transcriptomic and proteomic profiles 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.